TMEM123 a key player in immune surveillance of colorectal cancer. 2023

Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
Istituto Nazionale Genetica Molecolare (INGM), Padiglione Romeo ed Enrica Invernizzi, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.

Colorectal cancer (CRC) is a leading cause of cancer-associated death. In the tumor site, the interplay between effector immune cells and cancer cells determines the balance between tumor elimination or outgrowth. We discovered that the protein TMEM123 is over-expressed in tumour-infiltrating CD4 and CD8 T lymphocytes and it contributes to their effector phenotype. The presence of infiltrating TMEM123+ CD8+ T cells is associated with better overall and metastasis-free survival. TMEM123 localizes in the protrusions of infiltrating T cells, it contributes to lymphocyte migration and cytoskeleton organization. TMEM123 silencing modulates the underlying signaling pathways dependent on the cytoskeletal regulator WASP and the Arp2/3 actin nucleation complex, which are required for synaptic force exertion. Using tumoroid-lymphocyte co-culture assays, we found that lymphocytes form clusters through TMEM123, anchoring to cancer cells and contributing to their killing. We propose an active role for TMEM123 in the anti-cancer activity of T cells within tumour microenvironment.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016246 Lymphocytes, Tumor-Infiltrating Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. Tumor Infiltrating Lymphocyte,Tumor-Derived Activated Cell,Tumor-Derived Activated Cells,Tumor-Infiltrating Lymphocyte,Tumor-Infiltrating Lymphocytes,Activated Cell, Tumor-Derived,Activated Cells, Tumor-Derived,Infiltrating Lymphocyte, Tumor,Infiltrating Lymphocytes, Tumor,Lymphocyte, Tumor Infiltrating,Lymphocyte, Tumor-Infiltrating,Lymphocytes, Tumor Infiltrating,Tumor Derived Activated Cell,Tumor Derived Activated Cells,Tumor Infiltrating Lymphocytes
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte
D018920 Coculture Techniques A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states. Cocultivation,Co-culture,Coculture,Co culture,Co-cultures,Cocultivations,Coculture Technique,Cocultures

Related Publications

Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2017, Trends in cancer,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2025, Seminars in cancer biology,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2025, Current molecular medicine,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
August 2019, Oncology letters,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2016, Gastroenterology research and practice,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
December 2022, Critical reviews in oncology/hematology,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
March 2025, Science signaling,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2014, Indian journal of cancer,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
November 2011, Cancer research,
Elisa Pesce, and Chiara Cordiglieri, and Mauro Bombaci, and Serenella Eppenberger-Castori, and Stefania Oliveto, and Cristina Manara, and Mariacristina Crosti, and Caner Ercan, and Mairene Coto, and Andrea Gobbini, and Susanna Campagnoli, and Tiziano Donnarumma, and Manuele Martinelli, and Valeria Bevilacqua, and Elisa De Camilli, and Paola Gruarin, and Maria L Sarnicola, and Elisa Cassinotti, and Ludovica Baldari, and Giuseppe Viale, and Stefano Biffo, and Sergio Abrignani, and Luigi M Terracciano, and Renata Grifantini
January 2012, Expert review of anticancer therapy,
Copied contents to your clipboard!